Mucin-type O-glycosylation is critical for vascular integrity

Glycobiology

Volumn 24, Issue 12, 2014, Pages 1237-1241

  Herzog, Brett H ^a,b   Fu, Jianxin ^a   Xia, Lijun ^a,b  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Clec 2; O glycosylation; Platelet; Podoplanin; Vascular integrity

Indexed keywords

GLYCAN; GLYCOPROTEIN; MUCIN; N ACETYLGALACTOSAMINE; PEPTIDE; PODOPLANIN; PROTEIN CLEC 2; SERINE; THREONINE; UNCLASSIFIED DRUG; POLYSACCHARIDE;

ANGIOGENESIS; BLOOD; BRAIN TISSUE; ENDOTHELIUM CELL; GLYCOSYLATION; IN VIVO STUDY; LYMPH NODE; LYMPH VESSEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; THROMBOCYTE; VASCULAR ENDOTHELIUM; ANIMAL; CHEMISTRY; HUMAN; METABOLISM;

ANIMALS; ENDOTHELIUM, VASCULAR; GLYCOSYLATION; HUMANS; MUCINS; POLYSACCHARIDES;

EID: 84925687731     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwu058     Document Type: Review

References (35)

1. Abtahian F, Guerriero A, Sebzda E, Lu MM, Zhou R, Mocsai A, Myers EE, Huang B, Jackson DG, Ferrari VA, et al. 2003. Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science. 299:247-251.
2. An G, Wei B, Xia B, McDaniel JM, Ju T, Cummings RD, Braun J, Xia L. 2007. Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans. J Exp Med. 204:1417-1429.
3. Bajenoff M, Egen JG, Koo LY, Laugier JP, Brau F, Glaichenhaus N, Germain RN. 2006. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity. 25:989-1001.
4. Ballabh P. 2010. Intraventricular hemorrhage in premature infants: Mechanism of disease. Pediatr Res. 67:1-8.
5. Bertozzi CC, Schmaier AA, Mericko P, Hess PR, Zou Z, Chen M, Chen CY, Xu B, Lu MM, Zhou D, et al. 2010. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood. 116:661-670.
6. Carmeliet P. 2000. Mechanis ms of angiogenesis and arteriogenesis. Nat Med. 6:389-395.
7. Chyou S, Ekland EH, Carpenter AC, Tzeng TC, Tian S, Michaud M, Madri JA, Lu TT. 2008. Fibroblast-type reticular stromal cells r egulate the lymph node vasculature. J Immunol. 181:3887-3896.
8. Dejana E. 1996. Endothelial adherens junctions: Implications in the control of vascular permeability and angiogenesis. J Clin Invest. 98: 1949-1953.
9. Dejana E, Tournier-Lasserve E, Weinstein BM. 2009. The control of vascular integrity by endothelial cell junctions: Molecular basis and pathological implications. Dev Cell. 16:209-221.
10. Drayton DL,Liao S,Mounzer RH,Ruddle NH 2006 Lymphoid organ development: From ontogeny to neogenesis Nat Immunol. 7, 344-353.
11. Fu J, Gerhardt H, McDaniel JM, Xia B, Liu X, Ivanciu L, Ny A, Hermans K, Silasi-Mansat R, McGee S, et al. 2008. Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice. J Clin Invest. 118:37 25-3737.
12. Girard JP, Moussion C, Forster R. 2012. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat Rev Immunol. 12:762-773.
13. Herzog BH, Fu J, Wilson SJ, Hess PR, Sen A, McDaniel JM, Pan Y, Sheng M, Yago T, Silasi-Mansat R, et al. 2013. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. Nature. 502:105-109.
14. Hess PR, Rawnsley DR, Jakus Z, Yang Y, Sweet DT, Fu J, Herzog B, Lu M, Nieswandt B, Oliver G, et al. 2014. Platelets mediate lymphovenous hemostasis to maintain blood-lymphatic separation throughou t life. J Clin Invest. 124:273-284.
15. Ichise H, Ichise T, Ohtani O, Yoshida N. 2009. Phospholipase Cgamma2 is necessary for separation of blood and lymphatic vasculature in mice. Development. 136:191-195.
16. Iwai T, Inaba N, Naundorf A, Zhang Y, Gotoh M, Iwasaki H, Kudo T, Togayachi A, Ishizuka Y, Nakanishi H, et al. 2002. Molecular cloning and characterization of a novel UDP-Gl cNAc:GalNAc-peptide beta1,3-Nacetylglucosaminyltransferase (beta 3Gn-T6), an enzyme synthesizing the core 3 structure of O-glycans. J Biol Chem. 277:12802-12809.
17. Ju T, Cummings RD. 2002. A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase. Proc Natl Acad Sci USA. 99:16613-16618.
18. Ju T, Cummings RD, Canfield WM. 2002. Purification, characterization, and subunit structure of rat core 1 beta1,3-galactosyltransferase. J Biol Chem. 277:169-177.
19. Kaneko MK, Kato Y, Kameyama A, Ito H, Kuno A, Hirabayashi J, Kubota T, Amano K, Chiba Y, Hasegawa Y, et al. 2007. Functional glycosylation of human podoplanin: Glycan structure of platelet aggregation-inducing factor. FEBS Lett. 581:331-336.
20. Kaneko M, Kato Y, Kunita A, Fujita N, Tsuruo T, Os awa M. 2004. Functional sialylated O-glycan to platelet aggregation on Aggrus (T1alpha/Podoplanin) molecules expressed in Chinese hamster ovary cells. J Biol Chem. 279:38838-38843.
21. Kornfeld R, Kornfeld S. 1 985. Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem. 54:631-664.
22. Kunkel EJ, Butcher EC. 2002. Chemokines and the tissue-specific migration of lymphocytes. Immunity. 16:1-4.
23. McEver RP. 2001. Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost. 86:746-756.
24. McEver RP, Cummings RD. 1997. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest. 100:S97-103.
25. Oliver G. 2004. Lymphatic vasculature development. Nat Rev Immunol. 4:35-45.
26. Rosen SD. 2004. Ligands for L-selectin: Homing, inflammation, and beyond. Annu Rev Immunol. 22:129-156.
27. Schacht V, Ramirez MI, Hong YK, Hirakawa S, Feng D, Harvey N, Williams M, Dvorak AM, Dvorak HF, Ol iver G, et al. 2003. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 22:3546-3556.
28. Suzuki-Inoue K, Kato Y, Inoue O, Kaneko MK, Mishima K, Yatomi Y, Yamazaki Y, Narimatsu H, Ozaki Y. 2007. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. J Biol Chem. 282:25993-26001.
29. Tran DT, Ten Hagen KG. 2013. Mucin-type O-glycosylation during development. J Biol Chem. 288:6921-6929.
30. Uhrin P, Zaujec J, Breuss JM, Olcaydu D, Chrenek P, Stockinger H, Fuertbauer E, Moser M, Haiko P, Fassler R, et al. 2010. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood. 115:3997-4005.
31. Varki A,Cummings R,Esko J,Freeze H,Stanley P,Bertozzi C,Hart G,Etzler M 2009 Essentials of Glycobiology Cold Spring Harbor (NY): Cold Spring Harbor Press.
32. von Andrian UH, Mempel TR. 2003. Homing and cellular traffic in lymph nodes. Nat Rev Immunol. 3:867-878.
33. Wang Y, Jobe SM, Ding X, Choo H, Archer DR, Mi R, Ju T, Cummings RD. 2012. Platelet biogenesis and functions require correct protein O-glycosylation. Proc Natl Acad Sci USA. 109:16143-16148.
34. Xia L, Ju T, Westmuckett A, An G, Ivanciu L, McDaniel JM, Lupu F, Cummings RD, McEver RP . 2004. Defective angiogenesis and fatal embryonic hemorrhage in mice lacking core 1-derived O-glycans. J Cell Biol. 164:451-459.
35. Yago T, Fu J, McDaniel JM, Miner JJ, McEver RP, Xia L. 2010. Core 1-derived O-glycans are essential E-selectin ligands on neutrophils. Proc Natl Acad Sci USA. 107:9204-9209.